RMF

KT-HEALTHC RMF

KTAM World Healthcare RMF

15.8114
+-0.1324       +-0.8304%
*NAV
15.8115
Offer
15.8114
Bid
980,615,742.15
*Net Asset Value
*(According to the fund's currency)
  Data as of 02/12/2025
      Data as of 31/10/2025
      Data as of 30/09/2025

Information

Fund type Open-end Equity Fund, RMF, Sector Fund, Feeder Fund
Risk Level 7
Investment Policy The fund mainly only invests in the units of the retail fund Janus Henderson Global Life Sciences Fund (Master Fund), averaging no less than 80% of NAV during the accounting year.
Master Fund Janus Henderson Global Life Sciences Fund - Class H2
Management Company (Master Fund) Janus Henderson Capital Management LLC
Investment Policy
(Master Fund)		 The Janus Henderson Global Life Sciences Fund aims to achieve long-term capital growth by investing globally in equities of companies worldwide whose businesses are involved in life-sciences, providing healthcare or wellness.
Currency (Master Fund) USD
Hedging Policy (in THB) Subjected to the discretion of the fund manager
Dividend Policy No Dividend
Minimum Subscription 500 Baht
Minimum Redemption None
Trading Hours Every business day of the fund from 8.30 – 15.30
Krung Thai Bank and Selling Agents
Internet Trading: KTAM SMART TRADE (www.ktam.co.th)
Settlement Period T+4
Management Fee Not exceeding 2.675% p.a.1
Trustee Fee Not exceeding 0.0749% p.a.1 
Registrar Fee Not exceeding 0.535% p.a.1
Bloomberg Ticker Ticker (Master Fund) : JGLSUAU
Ticker : KTHCRMF:TB
1This rate includes VAT, special business tax, and other similar taxes.
*Support PVD transfer

Portfolio information

Asset allocation proportions (Data as of 31/10/2025)
Securities with the highest investment value 5 First rank (Data as of 31/10/2025)
Securities Credit rating (% NAV)
Unit Trust Janus Global Life Sciences Fund N/A 98.91
Top 5 assets invested in the main fund (Data as of 31/10/2025)
  • Asset
    (% NAV)
  • Eli Lilly and Co
    8.67
  • Johnson & Johnson
    5.04
  • AstraZeneca PLC
    4.17
  • UnitedHealth Group Inc
    3.83
  • AbbVie Inc
    3.36
Master Fund Information as of 31/10/25
Investment allocation by industry group of the main fund (Data as of 31/10/2025)
  • Industry group
    (% NAV)
  • Healthcare
    100.00
Master Fund Information as of 31/10/25
Foreign investment allocation of the main fund (Data as of 31/10/2025)
  • Country
    (% NAV)
  • UNITED STATES
    85.31
  • UNITED KINGDOM
    4.23
  • SWITZERLAND
    3.90
  • FRANCE
    2.69
  • DENMARK
    1.57
Master Fund Information as of 31/10/25
Investment in other funds exceeding 20% (domestic and/or foreign funds) (Data as of 31/10/2025)
  • Fund Name : Unit Trust Janus Global Life Sciences Fund
    ISIN code : IE00BFRSYJ83
    Bloomberg code : JGLSUAU ID

Statistical information (Data as of 31/10/2025)
  • Maximum Drawdown
    -23.30 %
  • Recovering Period
    N/A
  • FX Hedging
    48.11 %
  • Portfolio Turnover Rate
    0.12
  • Sharpe Ratio
    0.12
  • Alpha
    -2.35
  • Beta
    0.58

Morningstar Rating data as of 31/10/2025
© Copyright 2025 Morningstar Research Thailand. This information (1) is the property of Morningstar and/or its data providers, (2) reproduction or distribution is prohibited, and (3) Morningstar does not guarantee accuracy or completeness and is not responsible for any damages arising from its use. Past performance is not indicative of future results.

Note: Please read and refer to the prospectus summary for more detailed information.

Investors must understand the product features, return conditions, and risks before making an investment decision.

NAV of Fund

Performance results

Time period Past Performance (%)
( Ending on date 31 October 2025 ) 		Volatility (Standard Deviation) (% per year)
KT-HEALTHC RMF Benchmark 1 Benchmark 2 KT-HEALTHC RMF Benchmark 1 Benchmark 2
Year-to-date return 7.81 10.87 - 19.81 20.06 -
Last 3 months 16.66 17.62 - 15.64 15.52 -
Last 6 months 9.36 11.34 - 17.52 17.40 -
Last 1 year -1.95 1.56 - 19.29 19.52 -
Last 3 years 2.48 4.83 - 15.99 17.62 -
Last 5 years 3.42 9.46 - 17.16 18.53 -
Last 10 years - - - - - -
Since fund inception 4.13 7.38 - 18.46 19.44 -

* Peer Group Fund Performance Report by AIMC

Benchmark 1 is The benchmark is the performance of the master fund adjusted for foreign exchange risk hedging costs conversion into Thai Baht, at approximately 80%, and conversion into Thai Baht 20%

Average Instrument Lifetime

Modified Duration 0.00

Benchmark 1 is The benchmark is the performance of the master fund adjusted for foreign exchange risk hedging costs conversion into Thai Baht, at approximately 80%, and conversion into Thai Baht 20%

Annual performance results

Year Past Performance (%) Volatility (Standard Deviation) (% per year)
KT-HEALTHC RMF Benchmark 1 Benchmark 2 KT-HEALTHC RMF Benchmark 1 Benchmark 2
2024 -2.07 -0.12 - 13.51 13.69 -
2023 0.04 9.26 - 14.33 18.10 -
2022 -6.39 -0.68 - 22.52 22.71 -
2021 6.06 17.83 - 14.36 14.02 -
2020 18.13 23.72 - 30.83 30.39 -
2019 24.33 20.55 - 14.22 14.68 -
2018 -1.31 0.60 - 16.57 16.61 -
2017 16.00 10.76 - 10.83 11.70 -
2016 -15.54 -14.62 - 19.96 20.59 -
2015 0.45 1.06 - 14.41 16.84 -

* Peer Group Fund Performance Report by AIMC

Benchmark 1 is The benchmark is the performance of the master fund adjusted for foreign exchange risk hedging costs conversion into Thai Baht, at approximately 80%, and conversion into Thai Baht 20%

Duration อายุเฉลี่ยตราสาร

Modified Duration 0.00

Note :

  • The fund performance is prepared in accordance with AIMC standards no. สจก.ร. 1/2566 by
    1. Past performance less than 1 year is % for each period (not annualize)
    2. Past performance more than 1 year is % per year (annualize)
  • The assessment of the fund's performance as shown on this website has been in accordance with the assessment standards set by the Association of Investment Management Companies (AIMC).
  • Past performance of the fund may not be indicative of future operation.

Download document

Monthly Fund Update